Kura Oncology Inc. (NASDAQ:KURA) rose 4.7% during mid-day trading on Tuesday . The stock traded as high as $5.45 and last traded at $5.38, with a volume of 141,664 shares changing hands. The stock had previously closed at $5.14.

KURA has been the subject of several research reports. Zacks Investment Research raised Kura Oncology from a “hold” rating to a “buy” rating and set a $3.75 price target for the company in a report on Wednesday, July 13th. Oppenheimer Holdings Inc. reaffirmed an “outperform” rating and set a $16.00 price target on shares of Kura Oncology in a report on Tuesday, June 21st.

The stock’s market capitalization is $94.46 million. The firm has a 50 day moving average price of $4.02 and a 200-day moving average price of $3.65.

Kura Oncology (NASDAQ:KURA) last issued its earnings results on Wednesday, August 10th. The company reported ($0.36) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.34) by $0.02. On average, analysts forecast that Kura Oncology Inc. will post ($1.72) EPS for the current fiscal year.

Kura Oncology, Inc is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing personalized therapeutics for the treatment of solid tumors and blood cancers. Its segment is engaged in the discovery and development of personalized therapeutics for the treatment of solid tumors and blood cancers.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.